News
LFCR
7.38
-1.07%
-0.08
Weekly Report: what happened at LFCR last week (0202-0206)?
Weekly Report · 2d ago
U.S. Earnings Preview: After Market Close Feb. 6
Dow Jones · 4d ago
Weekly Report: what happened at LFCR last week (0126-0130)?
Weekly Report · 02/02 10:09
Lifecore Biomedical (LFCR) Receives a Buy from Craig-Hallum
TipRanks · 02/01 16:25
Weekly Report: what happened at LFCR last week (0119-0123)?
Weekly Report · 01/26 10:09
Earnings Preview: After Market Close Jan. 23
Dow Jones · 01/23 20:31
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity
Simply Wall St · 01/20 10:24
Weekly Report: what happened at LFCR last week (0112-0116)?
Weekly Report · 01/19 10:14
Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan
TipRanks · 01/16 21:47
LIFECORE ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 01/16 21:45
Lifecore Biomedical Launches New Incentive Bonus Plan for Executives and Employees
Reuters · 01/16 21:29
Earnings Preview: After Market Close Jan. 16
Dow Jones · 01/16 20:31
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Barchart · 01/15 09:39
Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water
Seeking Alpha · 01/14 06:05
Weekly Report: what happened at LFCR last week (0105-0109)?
Weekly Report · 01/12 10:14
Weekly Report: what happened at LFCR last week (1229-0102)?
Weekly Report · 01/05 10:08
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR)
TipRanks · 01/02 14:30
Lifecore Biomedical: The Turnaround Is Just Getting Started
Seeking Alpha · 01/01 13:50
Weekly Report: what happened at LFCR last week (1222-1226)?
Weekly Report · 12/29/2025 10:08
KeyBanc says momentum, strategic value building at Lifecore
TipRanks · 12/29/2025 10:05
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.